Effect of leukotriene modifier drugs on the safety of oral aspirin challenges

This publication has 17 references indexed in Scilit:

• The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease
  Annals of Allergy, Asthma & Immunology, 2005
• Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice
  BMJ, 2004
• Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA‐sensitive asthmatics: a controlled study vs placebo
  Allergy, 2004
• Aspirin intolerance and the cyclooxygenase???leukotriene pathways
  Current Opinion in Pulmonary Medicine, 2004
• Natural History and Clinical Features of Aspirin-Exacerbated Respiratory Disease
  Clinical Reviews in Allergy & Immunology, 2003
• The effect of leukotriene‐modifier drugs on aspirin‐induced asthma and rhinitis reactions
  Clinical and Experimental Allergy, 2002
• Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics
  Annals of Allergy, Asthma & Immunology, 2000
• Genetics of aspirin induced asthma
  Thorax, 2000
• Characterization of the Human Cysteinyl Leukotriene 2 Receptor
  Journal of Biological Chemistry, 2000
• Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma
  Journal of Allergy and Clinical Immunology, 1994